LINCOLN, Mass., Sept. 25, 2017 /PRNewswire/ -- Applied BioMath
(www.appliedbiomath.com), the industry-leader in applying
mechanistic modeling to drug research and development, today
announced their participation in an upcoming quantitative systems
pharmacology (QSP) event hosted by the Pharmaceutical and
BioScience Society (PBSS) on September 29,
2017 in Boston,
MA. Applied BioMath is the sole major sponsor of
the day-long event as well as a presenter of two case studies in
immuno-oncology and osteoarthritis.
Dr. John Burke, PhD, Co-Founder,
President, and CEO of Applied BioMath, will present two case
studies, one highlighting an example of integrating systems
modeling to predict optimal drug properties targeting PD-1 and TIM3
in immuno-oncology for bispecific biologics and fixed dose
combinations, and a second showing QSP approaches to determine best
in class properties for targeted anabolic growth factor to
arthritic joints.
"Our proprietary QSP modeling approach has a proven track record
of helping biotechnology and pharmaceutical companies better
understand their drug candidate's mechanism of action in the
context of human disease mechanisms. Our model results have
impacted optimal lead generation design and better enabled clinical
candidate selection and IND submission," said Dr. John Burke, PhD, Co-Founder, President, and CEO
of Applied BioMath. "These case studies are just two of many
examples we have where our participation in the project has
de-risked projects, accelerated the discovery and development of
best-in-class therapeutics, and impacted critical decisions, in the
continuum from preclinical exploration to clinical research."
Immediately prior to this event, Dr. Burke will present at the
8th Annual World Bispecific Summit in Boston, MA. Additionally, Dr.
Burke will present a variety of case studies at the American
Conference of Pharmacometrics (AcoP) October
15-18, 2017 in Ft. Lauderdale, Florida. For more
information on any of these events, please visit
www.appliedbiomath.com/events.
About Applied BioMath
Applied BioMath (www.appliedbiomath.com), the industry-leader in
applying mechanistic modeling to drug research and development,
helps biotechnology and pharmaceutical companies answer
complex, critical Go/No-go decisions in
R&D. Applied BioMath leverages biology,
proprietary mathematical modeling and analysis technology,
high-performance computing, and decades of industry experience to
help groups better understand their candidate, its best-in-class
parameters, competitive advantages, and the best path
forward. Our involvement shortens project timelines, lowers
cost, and increases the likelihood of a best-in-class drug.
We provide clarity to complex situations, answer otherwise
unanswerable questions, and our approach, when validated in the
clinic, is 10x more accurate than traditional methodologies.
Applied BioMath and the Applied BioMath logo are trademarks of
Applied BioMath, LLC.
Press contact:
Kristen Zannella
kristen.zannella@appliedbiomath.com
View original content with
multimedia:http://www.prnewswire.com/news-releases/applied-biomath-llc-announced-as-major-sponsor-and-presenter-at-the-model-informed-drug-discovery-and-development-using-quantitative-systems-pharmacology-modeling-qsp-an-industry-and-regulatory-perspective-event-in-boston-ma-300525025.html
SOURCE Applied BioMath